Clinical trials
Leukemia, Myeloid, Acute trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2009 | 4 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 7 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 9 |
| Terminated | 9 |
| Active, not recruiting | 8 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 5 |
| Novartis Pharmaceuticals | 4 |
| Vastra Gotaland Region | 3 |
| AbbVie | 2 |
| Astex Pharmaceuticals, Inc. | 2 |
| Daiichi Sankyo | 2 |
| Advesya SAS | 1 |
| Akinion Pharmaceuticals AB | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 43 |
| Leukemia | 7 |
| Myelodysplastic Syndromes | 7 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Recurrence | 5 |
| Leukemia, Myelomonocytic, Chronic | 4 |
| Multiple Myeloma | 4 |
| Graft vs Host Disease | 3 |
| Hematologic Neoplasms | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
Trials
Showing 26 to 43 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.